'Once He Knew the Source, Fetterman Ate Him Alive' — Senator Shut Down...
Jessica Tarlov Says Dems Need More Troy Jackson-Style Anonymous Account Trolling Energy (R...
A Gentle Reminder: The Science Writer Who Labeled COVID Lab Leak Racist Still...
Eagles Defensive Coordinator Mocks Dr. Fauci to Escape a Reporter's Question
Yikes: Official WNBA Account Posts Players Betting on Itselves, Then Scrubs the Evidence
Look at This Insane Video From Spain for a Reminder of What Dem/DSA...
Detroit Rev. Picks Stevens Because El-Sayed Won’t Shut Up About Gaza Long Enough...
'Made Me Sick': Ex DNI Tulsi Gabbard Reminds Everyone Why Dr. Fauci Took...
'Jail Won’t Fix His Heart': NYU Student Defends Letting Rapists, Including Her Own,...
Fetterman Tells Bernie to Sit This One Out; Sanders Fires Back, Questions Whether...
Basement Hermit Michael Tracey Shocked That People Whose Lives Were Ruined Still Care...
Sen. Eric Schmitt Digs Up a Fauci-Related Flashback From NPR to Let Them...
Joyce Carol Oates Calls Criticism of Nolan’s ‘The Odyssey’ the 'Crude Language of...
The Atlantic Says the Fauci Hearing Was Full of 'Unchallenged Allegations' (Yeah, About...
Let's Check in With How the DNC's Male Voter Outreach Is Going

Christina Pushaw busts the AP for acknowledging a COVID treatment fact they shamed Ron DeSantis for pointing out just a few months ago

Yesterday, the Associated Press’ Matthew Perrone reported a possible setback for a couple of COVID19 treatments, including Regeneron.

Advertisement

More from the AP:

As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.

For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital.

But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which contains dozens of mutations that make it harder for antibodies to attack the virus. And while the companies say they can quickly develop new omicron-targeting antibodies, those aren’t expected to launch for at least several months.

The fact that Regeneron may not be as effective against the omicron variant as it’s been against others is noteworthy enough. But Gov. Ron DeSantis’ press secretary Christina Pushaw finds something else noteworthy, too:

Things sure have changed, haven’t they? Recall this past August, when the AP was entertaining the idea that DeSantis was promoting sketchy Regeneron in some kind of quid pro quo scheme because one of his top donors had invested money in Regeneron, making DeSantis shady AF and not to be trusted.

Advertisement

Pushaw called out the AP then.

Just like she’s calling out the AP now.

We’ve got whiplash.

And Pushaw’s got one last question for the AP:

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos

Advertisement
Advertisement
Advertisement